Develops and manufactures oral fluid diagnostic products. Offers rapid tests for infectious diseases like HIV, Hepatitis C, and Ebola. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 16% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
The cash pile is strong; debt and other items pull the grade toward the middle.
The price looks reasonable next to what the company earns.
Clearly below the class average.
Clearly below the class average.
Growth: Sales growth trails the sector average.
Business Quality: Profit power and business quality trail similar companies in the sector.
An investor who bought at the very peak is down 71% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $199.3M in the vault; even if every debt were paid off, $186.1M would remain.
Over the last 12 months, company executives reported 25 buys and 12 sells. Management buying with its own money is usually read as a good sign.
A loss of $68.7M against $115.0M in annual sales. And on top of that, sales fell from the year before.
The growth engine is running at low revs right now. Report-card grade: 2/100.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 39/100.
On our five-subject report card, OSUR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: OSUR’s sales are going backwards, and it closed last year at a loss. The road back runs through both.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.